Research
Title : | New therapeutics against SARS–CoV-2: Analysing small molecule chemical libraries by establishing targeted cell-based assays for inhibitors of viral entry and viral protease |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology |
Focus area : | Therapeutics for SARS-Cov-2 |
Principal Investigator : | Dr E Sreekumar, Scientist, Rajiv Gandhi Centre for Biotechnology (RGCB), Kerala |
Timeline Start Year : | 2020 |
Contact info : | esreekumar@rgcb.res.in |
Details
Executive Summary : | The study aims to develop cell-based assays to identify inhibitors of SARS-CoV-2 entry and also inhibitors of viral protease. It also plans to screen derivatives of Arbidol as virus entry inhibitors. |
Organizations involved
Implementing Agency : | Rajiv Gandhi Centre for Biotechnology (RGCB), Kerala Funding Agency :Department of Biotechnology (DBT) Govt. of India | |